300 related articles for article (PubMed ID: 26718919)
41. The Potential Use of Plant Natural Products and Plant Extracts with Antioxidant Properties for the Prevention/Treatment of Neurodegenerative Diseases: In Vitro, In Vivo and Clinical Trials.
Pohl F; Kong Thoo Lin P
Molecules; 2018 Dec; 23(12):. PubMed ID: 30544977
[TBL] [Abstract][Full Text] [Related]
42. A potential role of alkaloid extracts from Salsola species (Chenopodiaceae) in the treatment of Alzheimer's disease.
Tundis R; Menichini F; Conforti F; Loizzo MR; Bonesi M; Statti G; Menichini F
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):818-24. PubMed ID: 18720188
[TBL] [Abstract][Full Text] [Related]
43. Perspectives for treating Alzheimer's disease: a review on promising pharmacological substances.
Cazarim Mde S; Moriguti JC; Ogunjimi AT; Pereira LR
Sao Paulo Med J; 2016; 134(4):342-54. PubMed ID: 27557144
[TBL] [Abstract][Full Text] [Related]
44. Ethnobotany, phytochemistry and pharmacology of Stephania rotunda Lour.
Desgrouas C; Taudon N; Bun SS; Baghdikian B; Bory S; Parzy D; Ollivier E
J Ethnopharmacol; 2014 Jul; 154(3):537-63. PubMed ID: 24768769
[TBL] [Abstract][Full Text] [Related]
45. Nature as a source of metabolites with cholinesterase-inhibitory activity: an approach to Alzheimer's disease treatment.
Pinho BR; Ferreres F; Valentão P; Andrade PB
J Pharm Pharmacol; 2013 Dec; 65(12):1681-700. PubMed ID: 24236980
[TBL] [Abstract][Full Text] [Related]
46. Phytochemical constituents and pharmacological properties of Garcinia xanthochymus- a review.
Che Hassan NKN; Taher M; Susanti D
Biomed Pharmacother; 2018 Oct; 106():1378-1389. PubMed ID: 30119210
[TBL] [Abstract][Full Text] [Related]
47. Natural products as sources of new lead compounds for the treatment of Alzheimer's disease.
Huang L; Su T; Li X
Curr Top Med Chem; 2013; 13(15):1864-78. PubMed ID: 23931437
[TBL] [Abstract][Full Text] [Related]
48. Targeting monoamine oxidases with multipotent ligands: an emerging strategy in the search of new drugs against neurodegenerative diseases.
Pisani L; Catto M; Leonetti F; Nicolotti O; Stefanachi A; Campagna F; Carotti A
Curr Med Chem; 2011; 18(30):4568-87. PubMed ID: 21864289
[TBL] [Abstract][Full Text] [Related]
49. Pharmacological evaluation of Alstonia scholaris: anti-inflammatory and analgesic effects.
Shang JH; Cai XH; Feng T; Zhao YL; Wang JK; Zhang LY; Yan M; Luo XD
J Ethnopharmacol; 2010 May; 129(2):174-81. PubMed ID: 20219658
[TBL] [Abstract][Full Text] [Related]
50. Berberis aetnensis and B. libanotica: a comparative study on the chemical composition, inhibitory effect on key enzymes linked to Alzheimer's disease and antioxidant activity.
Bonesi M; Loizzo MR; Conforti F; Passalacqua NG; Saab A; Menichini F; Tundis R
J Pharm Pharmacol; 2013 Dec; 65(12):1726-35. PubMed ID: 24236982
[TBL] [Abstract][Full Text] [Related]
51. Natural antioxidants in Alzheimer's disease.
Mancuso C; Bates TE; Butterfield DA; Calafato S; Cornelius C; De Lorenzo A; Dinkova Kostova AT; Calabrese V
Expert Opin Investig Drugs; 2007 Dec; 16(12):1921-31. PubMed ID: 18042001
[TBL] [Abstract][Full Text] [Related]
52. Anti-inflammatory, Anti-bacterial and Anti-acetylcholinesterase Activities of two Isoquinoline Alkaloids-Scoulerine and Cheilanthifoline.
Wangchuk P; Sastraruji T; Taweechotipatr M; Keller PA; Pyne SG
Nat Prod Commun; 2016 Dec; 11(12):1801-1804. PubMed ID: 30508337
[TBL] [Abstract][Full Text] [Related]
53. Natural Anti-inflammatory Compounds as Drug Candidates in Alzheimer's Disease.
Mir RH; Shah AJ; Mohi-Ud-Din R; Pottoo FH; Dar MA; Jachak SM; Masoodi MH
Curr Med Chem; 2021; 28(23):4799-4825. PubMed ID: 32744957
[TBL] [Abstract][Full Text] [Related]
54. Multi-Target Directed Compounds with Antioxidant and/or Anti- Inflammatory Properties as Potent Agents for Alzheimer's Disease.
Papagiouvannis G; Theodosis-Nobelos P; Kourounakis PN; Rekka EA
Med Chem; 2021; 17(10):1086-1103. PubMed ID: 33050864
[TBL] [Abstract][Full Text] [Related]
55. Potential benefits of phytochemicals against Alzheimer's disease.
Wightman EL
Proc Nutr Soc; 2017 May; 76(2):106-112. PubMed ID: 28143625
[TBL] [Abstract][Full Text] [Related]
56. A pharmacological and phytochemical overview on Satureja.
Tepe B; Cilkiz M
Pharm Biol; 2016; 54(3):375-412. PubMed ID: 25955956
[TBL] [Abstract][Full Text] [Related]
57. Phytochemicals from Dodonaea viscosa and their antioxidant and anticholinesterase activities with structure-activity relationships.
Muhammad A; Tel-Çayan G; Öztürk M; Duru ME; Nadeem S; Anis I; Ng SW; Shah MR
Pharm Biol; 2016 Sep; 54(9):1649-55. PubMed ID: 26866457
[TBL] [Abstract][Full Text] [Related]
58. Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment.
Musiał A; Bajda M; Malawska B
Curr Med Chem; 2007; 14(25):2654-79. PubMed ID: 17979717
[TBL] [Abstract][Full Text] [Related]
59. Determination of Parameters of Oxidative Stress in vitro Models of Neurodegenerative Diseases-A Review.
Feitosa CM; da Silva Oliveira GL; do Nascimento Cavalcante A; Morais Chaves SK; Rai M
Curr Clin Pharmacol; 2018; 13(2):100-109. PubMed ID: 29493463
[TBL] [Abstract][Full Text] [Related]
60. Research Progress on Neuroprotective Effects of Isoquinoline Alkaloids.
Li J; Wu Y; Dong S; Yu Y; Wu Y; Xiang B; Li Q
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
